Atıf Formatları
Results of concurrent chemoradiotherapy (CRT) with low dose weekly gemcitabine (G) in stage III non-small cell lung cancer (NSCLC)
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

U. Abacioglu Et Al. , "Results of concurrent chemoradiotherapy (CRT) with low dose weekly gemcitabine (G) in stage III non-small cell lung cancer (NSCLC)," JOURNAL OF CLINICAL ONCOLOGY , vol.22, no.14_suppl, pp.7318, 2004

Abacioglu, U. Et Al. 2004. Results of concurrent chemoradiotherapy (CRT) with low dose weekly gemcitabine (G) in stage III non-small cell lung cancer (NSCLC). JOURNAL OF CLINICAL ONCOLOGY , vol.22, no.14_suppl , 7318.

Abacioglu, U., Yumuk, P. F., Caglar, H., Sengoz, M., & Turhal, N. S., (2004). Results of concurrent chemoradiotherapy (CRT) with low dose weekly gemcitabine (G) in stage III non-small cell lung cancer (NSCLC). JOURNAL OF CLINICAL ONCOLOGY , vol.22, no.14_suppl, 7318.

Abacioglu, Mehmet Et Al. "Results of concurrent chemoradiotherapy (CRT) with low dose weekly gemcitabine (G) in stage III non-small cell lung cancer (NSCLC)," JOURNAL OF CLINICAL ONCOLOGY , vol.22, no.14_suppl, 7318, 2004

Abacioglu, Mehmet U. Et Al. "Results of concurrent chemoradiotherapy (CRT) with low dose weekly gemcitabine (G) in stage III non-small cell lung cancer (NSCLC)." JOURNAL OF CLINICAL ONCOLOGY , vol.22, no.14_suppl, pp.7318, 2004

Abacioglu, U. Et Al. (2004) . "Results of concurrent chemoradiotherapy (CRT) with low dose weekly gemcitabine (G) in stage III non-small cell lung cancer (NSCLC)." JOURNAL OF CLINICAL ONCOLOGY , vol.22, no.14_suppl, p.7318.

@article{article, author={Mehmet Ufuk ABACIOGLU Et Al. }, title={Results of concurrent chemoradiotherapy (CRT) with low dose weekly gemcitabine (G) in stage III non-small cell lung cancer (NSCLC)}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2004, pages={7318} }